A new clinical trial report finds that stereotactic radiation therapy offers long-term survival outcomes comparable to surgery for patients with small, early-stage non-small cell lung cancer (NSCLC).
Dr. Sandip Patel discusses findings from a real-world study of biomarker testing in early-stage resected non-small cell lung cancer in the U.S.
Cancer cells transfer mitochondria through nanotubes to healthy neighboring cells, turning them into tumor-supporting accomplices, a new study shows.
Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the ...
Dr. Jacob A. Sands shares how patients with lung cancer can interpret clinical trial results and how these findings translate ...
Dr. Anshul clarifies that while early breast cancer improves survival rates, recurrence risk remains high, especially in ...
Since the development of crizotinib (Xalkori), oncologists can now choose from an array of later-generation drugs in the ...
FLORHAM PARK, N.J. and LONDON and CHARLOTTESVILLE, Va., Sept (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (“Cellectar”) ...
Doctors are experimenting with using lower doses of blockbuster cancer drugs. It could help hundreds of thousands of lives — ...
Many of those women will have dense breasts. Research shows women with extremely dense breast tissue are up to six times more ...
Dr. Singhi speaks with us about the importance of biomarker testing and what you need to know to get the best lung cancer ...
When you're facing metastatic breast cancer, the questions can pile up fast. Here are some clear answers to guide you.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback